The ROE as of November 2024 (TTM) for Cyclo Therapeutics, Inc. (CYTH) is 749.85%

According to Cyclo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 749.85%. This represents a change of -562.69% compared to the average of -162.06% of the last 4 quarters.

Cyclo Therapeutics, Inc. (CYTH) Historical ROE (quarterly & annually)

How has CYTH ROE performed in the past?

The mean historical ROE of Cyclo Therapeutics, Inc. over the last ten years is -462.02%. The current 749.85% ROE has changed -262.30% with respect to the historical average. Over the past ten years (40 quarters), CYTH's ROE was at its highest in in the March 2022 quarter at 1.25%. The ROE was at its lowest in in the March 2024 quarter at -711.96%.

Cyclo Therapeutics, Inc. (CYTH) ROE by Quarter and Year

Discovering the peaks and valleys of Cyclo Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cyclo Therapeutics, Inc. (CYTH) Average ROE

How has CYTH ROE performed in the past?

The current ROE of Cyclo Therapeutics, Inc. (CYTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cyclo Therapeutics, Inc. (CYTH) ROE vs. Peers

How is CYTH’s ROE compared to its peers?

Cyclo Therapeutics, Inc.’s ROE is less than Athenex, Inc. (21.51%), greater than MedMen Enterprises Inc. (-96.37%), less than Lifecore Biomedical, Inc. (17.23%), greater than Lucy Scientific Discovery Inc. (-296.96%), less than Guardion Health Sciences, Inc. (77.24%), less than Agile Therapeutics, Inc. (104.04%), greater than Alpha Teknova, Inc. (-37.32%), greater than Petros Pharmaceuticals, Inc. (-76.66%), greater than Phibro Animal Health Corporation (6.59%), less than SOHM, Inc. (105.08%), greater than Silver Spike Investment Corp. (5.74%), less than Eagle Pharmaceuticals, Inc. (17.39%), greater than Intra-Cellular Therapies, Inc. (-9.93%), greater than Ironwood Pharmaceuticals, Inc. (-7.63%), less than Amneal Pharmaceuticals, Inc. (354.22%), less than Aquestive Therapeutics, Inc. (62.93%), greater than Assertio Holdings, Inc. (-51.19%), greater than AcelRx Pharmaceuticals, Inc. (-39.88%),

Build a custom stock screener for Cyclo Therapeutics, Inc. (CYTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyclo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cyclo Therapeutics, Inc. (CYTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cyclo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.